Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults

Clinical trial NCT05409196 · COMPLETED

Trial details

NCT number: NCT05409196
Sponsor: Eveliqure Biotechnologies GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diarrheal Disease, Infectious Gastrointestinal Disease Reactive Arthritis

Start date: 2020-09-16
Primary completion: 2021-06-21
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.